Overview and Scope
Imaging chemicals refers to chemicals that are used to develop or output images. Imaging chemicals are used to print package labels, output diagnostics images, and others.
Sizing and Forecast
The imaging chemicals market size has grown strongly in recent years. It will grow from $25.15 billion in 2023 to $26.81 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to consumer adoption of photography, graphic arts and printing, medical imaging, industrial imaging applications, demand for high-quality prints, film-based cinematography..
The imaging chemicals market size is expected to see strong growth in the next few years. It will grow to $34.63 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to printed electronics, increased demand for security imaging, demand for sustainable solutions, bio-based and renewable resources, functional imaging materials.. Major trends in the forecast period include digital transformation in imaging, advanced photographic printing technologies, customization for specialized applications, smart imaging materials, collaborations for innovation..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/imaging-chemicals-global-market-report
Segmentation & Regional Insights
The imaging chemicals market covered in this report is segmented –
1) By Product Type: Imaging Agents and Toners, Printing Inks, Image Developers
2) By Application: Medical Diagnostics, Packaging and Printing, Textile Processing, Mining, Other Applications
Asia-Pacific was the largest region in the imaging chemicals market in 2023. The regions covered in the imaging chemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9184&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of cancer & brain disorders is driving the growth of the imaging chemicals market. Cancer is any of a large number of diseases characterized by the uncontrollable division of abnormal cells, whereas brain disorders are diseases of the central and peripheral nervous systems. The rising prevalence of cancer and brain disorders is fueling the growth of the imaging chemicals, which offers benefits such as real-time monitoring, determining the stage and precise location of cancer to aid in the direction of surgery and other cancer treatments, and visualizing cellular activity. For instance, in October 2023, according to the EU Science Hub, a Belgium-based website of the European Commission’s Joint Research Centre, new cancer cases increased by 2.3% from 2020 to 2.74 million in 2022. Similarly, cancer mortality increased by 2.4% between 2010 and 2020. In October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, brain illnesses are the world’s second-greatest cause of mortality and the main cause of disability. Therefore, the increasing prevalence of cancer & brain disorders is expected to propel the growth of the imaging chemicals market.
Key Industry Players
Major companies operating in the imaging chemicals market are adopting a strategic partnership approach, aiming for research and development and commercializing imaging chemicals. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in December 2021, Guerbet Group, a France-based imaging chemical and pharmaceutical company, announced a strategic alliance with Bracco Imaging SpA. Companies are going to work on production and R&D for future indications, and gadopiclenol will be commercialized separately under various trademarks. Gadopiclenol is a next-generation macrocyclic contrast agent with excellent relaxivity that is designed to improve lesion identification and visualization in MRI while using fewer gadolinium dosages than existing agents on the market. Gadopiclenol will provide a perfect complement to Guerbet’s UNIK MRI solutions, comprising contrast media, injectors, consumables, services, and software. It enables customers to utilize less gadolinium in their daily clinical practice. Bracco Imaging SpA is an Italy-based imaging company.
The imaging chemicals market report table of contents includes:
1. Executive Summary
2. Imaging Chemicals Market Characteristics
3. Imaging Chemicals Market Trends And Strategies
4. Imaging Chemicals Market – Macro Economic Scenario
5. Global Imaging Chemicals Market Size and Growth
….
31. Global Imaging Chemicals Market Competitive Benchmarking
32. Global Imaging Chemicals Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Imaging Chemicals Market
34. Imaging Chemicals Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
